| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | -0.032 | 0.5 |
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | MG-132 | GDSC1000 | pan-cancer | AAC | -0.029 | 0.6 |
| mRNA | tubastatin A | GDSC1000 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | BRD-K41597374 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | Platin | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | 0.061 | 0.6 |